Side-by-side comparison of AI visibility scores, market position, and capabilities
Boden Sweden green hydrogen steel plant (rebranded from H2 Green Steel to Stegra 2024); €6.5B funded with 800MW electrolyzer and Volvo/Mercedes/Porsche pre-sales at 20-30% premium targeting 5M tonnes by 2030.
Stegra (formerly H2 Green Steel, rebranded 2024) is a Boden, Sweden-based green steel manufacturer — backed with approximately €6.5 billion in total funding from investors including Schaeffler (€100M total), Vargas Holding, and 20+ strategic and financial investors spanning the founder of Spotify to industrial corporations — building Europe's first large-scale green hydrogen steel plant in Boden, 45 miles south of the Arctic Circle, with operations expected by end of 2025 and commercial production ramping in 2026 toward 5 million tonnes annually by 2030. Founded in 2020 by Vargas Holding (the same investment group behind Northvolt), Stegra is led by CEO Henrik Henriksson (former CEO of Scania). The Boden facility features Europe's largest green hydrogen electrolyzer (800 MW), a MIDREX H2 DRI (direct reduced iron) plant, and a downstream steel mill supplied by SMS Group — replacing the coal-based blast furnace process with green hydrogen electrolysis, producing steel with up to 95% less CO2 than conventional production. Stegra has pre-sold over 50% of planned production capacity at 20-30% price premiums to customers including Volvo Group, Mercedes-Benz, Porsche, and IKEA's parent Ingka Group.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.